1.6K
Articles
47.8K
Citations
3.2
avg. Impact Factor
92
h-index

Most Cited Articles of Department of Oncology in 2002

TitleJournalYearCitations
Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy studyMolecular Pharmacology2002208
Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cellsBiochemical Pharmacology2002143
Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF kappa B activationBiochemical Pharmacology2002113
The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cellsMolecular Carcinogenesis200256
HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivityCancer200234
Simple and efficient liposomal encapsulation of topotecan by ammonium sulfate gradient: stability, pharmacokinetic and therapeutic evaluationAnti-Cancer Drugs200228
Prognostic value of multidrug resistance 1, glutathione-S-transferase-pi and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapyOncology200226
Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancerBritish Journal of Cancer200222
Simultaneous genotyping of single nucleotide polymorphisms in the IL-6, IL-10, TNFalpha and TNFbeta genesTissue Antigens200220
Simultaneous genotyping of single nucleotide polymorphisms in the IL-1 gene complex by multiplex polymerase chain reaction-restriction fragment length polymorphismJournal of Immunological Methods200219
Accuracy of the convolution/superposition dose calculation algorithm at the condition of electron disequilibriumApplied Radiation and Isotopes200211
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinomaCancer20029
Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatinAnticancer Research20029
Combination of 13-cis retinoic acid and interferon-alpha in the treatment of recurrent or refractory peripheral T-cell lymphomaLeukemia and Lymphoma20028
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracilAnticancer Research20027
Surface dose with grids in electron beam radiation therapyApplied Radiation and Isotopes20024
Pre-clinical and early-phase clinical studies of curcumin as chemopreventive agent for endemic cancers in TaiwanJapanese Journal of Cancer and Chemotherapy20024
Monte Carlo simulation of surface percent depth doseApplied Radiation and Isotopes20023